This clinical trial identifies essential components of an integrative mind-body sexual well-being intervention that is being designed to support the needs of women who have completed colorectal or anal cancer treatment and
experience concerns related to changes in sexual well-being and intimacy. Many women survivors of gastrointestinal (GI) cancer, including colorectal or anal cancer experience concerns related to their sexual well-being. Women’s sexual health is connected to stress and emotional well-being and is sometimes difficult to treat using medication alone. Therefore, researchers are designing a psychologically-informed mind-body stress reduction intervention for women to enhance this important part of life during cancer survivorship. A mind-body sexual well-being intervention may enhance women’s sexual well-being in colorectal and anal cancer survivorship.
Additional locations may be listed on ClinicalTrials.gov for NCT06331403.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVE:
I. To conduct a single-arm feasibility trial to examine the feasibility and acceptability of delivering a group-based mind-body sexual well-being intervention delivered via videoconference technology for up to 20 women who have completed treatment for colorectal or anal cancer.
SECONDARY OBJECTIVE:
I. Explore the preliminary effects of the intervention on psychosocial measures of satisfaction with sex life and impact of functional limitations, coping abilities, acceptance of body image changes, loneliness, and anticipated stigma.
OUTLINE:
Patients participate in mind-body sexual well-being group sessions virtually over 90 minutes each consisting of mind-body medicine and educational resources (e.g., dilators, lubricants, and moisturizers) related to survivors’ sexual well-being once weekly (QW) for 6 weeks.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorLucy Finkelstein-Fox
